Article Text

Download PDFPDF
Device failure weeks to months after transcatheter closure of secundum type atrial septal defects
  1. Thomas Bartel1,
  2. Nikolaos Bonaros2,
  3. Silvana Müller1
  1. 1Department of Internal Medicine III, Division of Cardiology, University Medical School Innsbruck, Innsbruck, Austria
  2. 2Department of Internal Medicine III, Division of Cardiac Surgery, University Medical School Innsbruck, Innsbruck, Austria
  1. Correspondence to Professor Thomas Bartel; thomas.bartel{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Two women at the age of 62 and 42 years underwent secundum type atrial septal defect (ASD) closure with the recently introduced ATRIASEPT II device (Cardia Inc, Eagan, Minnesota, USA). ASD closure devices of size 24 mm and 20 mm were implanted without complications. Intracardiac echocardiography demonstrated satisfactory device deployment. The first patient developed atrial fibrillation approximately 6 weeks after the procedure and therefore …

View Full Text


  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; not externally peer reviewed.